1. In: Braunwald EB, editor. Heart disease : A textbook of cardiovascular medicine 2001;6th ed. Philadelphia: WB Saunders. 1114-1231.
3. White HD. Thrombolytic therapy and equivalence trials. J Am Coll Cardiol 1998;31:494-496.
4. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators : Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction : The ASSENT-2 double-blind randomised trial : Assessment of the Safety and Efficacy of a New Thrombolytic Investigators. Lancet 1999;354:716-722.
5. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Smith SC Jr, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction : a report of the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol 2000;36:970-1062.
6. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Theroux P, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002 : a report of the ACC/AHA Task Force on Practice Guidelines. Circulation 2002;106:1893-1900.
7. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syncrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med 1998;338:1488-1497.
8. Inhibition of platelet glycoprotein IIb/IIIa receptor with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina : Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998;339:436-443.
9. ISIS-2(Second International Study of Infarct Survival) Colaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,817 cases of suspected acute myocardial infarction. Lancet 1988;2:349.
10. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996;348:1329-1339.
11. The CURE investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation. N Engl J Med 2001;109:52-58.
12. Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S, et al. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation : a meta-analysis. Lancet 2000;355:1936-1942.
13. AHA/ACC/ACP-ASIM guidelines for the management of the patients with chronic stable angina : Executive Summary and Recommendations. Circulation 1999;99:2829-2848.
14. Opie LH. First line drugs in chronic stable effort angina-the case for newer, longer-acting calcium channel blocking agents. J Am Coll Cardiol 2000;36:1967-1971.
15. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an ACE inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000;342:145-153.
16. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Williams SV, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina : a report of the ACC/AHA Task Force on Practice Guidelines. Circulation 2003;107:149-158.
17. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-853.
18. Executive Summary of the third report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel III). JAMA 2001;285:2486-2497.